Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04477785 · ClinicalTrials.gov registry record
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
A clinical trial of Parkinson Disease, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- Recruiting
- Registry status
- 4,500
- Enrollment target
- 20
- Study locations
NCT04477785 is a study of Parkinson Disease that is actively recruiting participants, run by Michael J. Fox Foundation for Parkinson's Research. The registered enrollment target is 4,500 participants, below the 5,311-participant average among 297 other Parkinson Disease trials with a reported enrollment target (15% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT04477785, a study of Parkinson Disease, is actively recruiting participants, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- RECRUITING
- Registry status
- 4,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Conditions Studied
Study Locations (20)
Arizona
- Barrow Neurological Institute - Phoenix
- Mayo Foundation for Medical Education and Research - Scottsdale
- Banner Research Institute - Sun City
California
- University of California San Diego - La Jolla
- Keck School of Medicine of USC - Los Angeles
- University of California, San Francisco - San Francisco
Florida
- Parkinson's Disease& Movement Disorder Center of Boca Raton - Boca Raton
- University of Florida - Gainesville
- University of South Florida - Tampa
Massachusetts
- Boston University - Boston
- Massachusetts General Hospital - Boston
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Connecticut
- Institute For Neurodegenerative Disorders - New Haven
Georgia
- Emory University School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,500 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2033-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04477785
The ClinicalTrials.gov registry entry for NCT04477785 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,311-participant average among 297 other Parkinson Disease trials with a reported enrollment target (15% lower). The listed sponsor is Michael J. Fox Foundation for Parkinson's Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04477785 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04477785 about?
NCT04477785 is a clinical study titled "PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort". The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest ...
What is the current status of trial NCT04477785?
This trial is currently recruiting. The enrollment target is 4,500 participants. The study started on 2020-07-01. Estimated completion is 2033-12.
What conditions does trial NCT04477785 study?
This clinical trial studies the following conditions: Parkinson Disease.
Who is sponsoring clinical trial NCT04477785?
This trial is sponsored by Michael J. Fox Foundation for Parkinson's Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04477785 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.